Starting tonight at 10:30 p.m. until Sunday at 8 a.m. we will be off the air for important maintenance. GPB Passport and GPB on YouTube and Hulu will still be available. We apologize for any inconvenience.
India's COVID-19 caseload plummeted to record lows in February. Now a startling spike is causing health systems — and possibly law and order — to break down. What went wrong?
A UNICEF report estimates that hundreds of thousands of babies in South Asia alone have died because of the inability of pregnant women to get appropriate care. India is seeking solutions.
They're majestic. They're neglected. And now they're slowly being fixed up. Conservationists are preserving them — and officials hope the fountains will supply free water for the city's impoverished.
India is the world's largest vaccine producer. But hundreds of its clinics have closed after running out of vaccine — just as the country sees a new spike in infections.
Meera Devi is on a mission to get her community heard — and facing discrimination and death threats in her work . She's featured in a new award-winning documentary, Writing With Fire.
Wednesday's death toll was 354. Scientists are investigating what's making cases of infection rise precipitously after a decline last fall. "This race is really against time," says one immunologist.
India is reporting its largest spike in new coronavirus cases since November. Its health ministry said that several concerning variants have been detected.
Weibo users face criminal charges after online comments — made in and outside China — casting doubt on the casualty number the Chinese government reported months after a brawl with Indian soldiers.
NPR tours the factory of the world's largest vaccine maker: Serum Institute of India. It's manufacturing nearly 100 million doses a month of the Oxford-AstraZeneca formula and exporting them globally.
The president was joined virtually by the leaders of Japan, India and Australia, in his first multilateral leaders' meeting. They launched a plan to boost vaccine production and distribution in Asia.
India's homegrown COVID-19 vaccine has been controversial because the Indian government approved its use before clinical trials showed it works. Now data is finally out.
Demonstrations have been going on for months. Pop stars and climate activists have pledged support for the farmers. What sparked the movement is less glamorous: New rules for wholesale markets.